Navigation Links
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Date:5/20/2008

Data from WELCOME Study Presented at Digestive Disease Week (DDW)

SAN DIEGO, May 20 /PRNewswire/ -- UCB today presented data at the Digestive Disease Week meeting that showed Cimzia(R) (certolizumab pegol) provided an effective and rapid clinical response in more than 60 percent of Crohn's disease patients who were intolerant, or no longer responding to infliximab. Over 39 percent of patients achieved remission by six weeks. Data also showed one-third of patients responded after receiving only the initial dose. [Abstract #494]

"Data from the UCB clinical trials program including the WELCOME and PRECiSE studies has demonstrated that certolizumab pegol is effective in inducing and sustaining clinical response in a broad range of patients with moderate to severe Crohn's disease," said David G. Binion, M.D., director, IBD Center and professor of medicine at the Medical College of Wisconsin in Milwaukee, Wis. "The addition of Cimzia(R) into our pharmacologic armamentarium to control chronic intestinal inflammation is an important advance for patients who suffer from Crohn's disease."

Cimzia(R) is the first and only PEGylated anti-TNFa (Tumor Necrosis Factor alpha) antibody approved for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have an inadequate response to conventional therapy. Cimzia(R), manufactured by UCB, was approved by the U.S. Food and Drug Administration (FDA) on April 22, 2008. The approval was based on safety and efficacy data from clinical trials in more than 1,500 patients with Crohn's disease.

The response rates in this study, measured by a decrease (greater than or equal to 100 points from baseline) in the Crohn's Disease Activity Index (CDAI) score, were comparable to those in an earlier study, the PRECiSE 2 trial, where 64 percent of patients in the overall population achieved response to Cimzia(R).

Cimzia(R) was
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
2. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
3. AlphaRx Provides Corporate and Development Update
4. PA Health Department Provides Hepatitis B Vaccinations, Discusses Risk Factors
5. Cipher provides regulatory update for CIP-TRAMADOL ER
6. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
7. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
8. Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain
9. Dubai Provides Aid for Cyclone Nargis Victims In Myanmar
10. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
11. Cholera study provides exciting new way of looking at infectious disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... at UT Southwestern Medical Center previously discovered that the ... adult heart lacks this ability. New research by the ... its incredible regenerative capability in adulthood, and the answer ... It is well-known that a major function of the ... But at the same time, oxygen is a highly ...
(Date:4/24/2014)... will bring together national experts to discuss solutions ... inaugural Brain Health Summit, titled "The Human Brain: ... Dr. Sandra Bond Chapman, founder and chief director ... Grassley (R-IA), U.S. Representative Chaka Fattah (D-PA) and ... Early Learning, U.S. Department of Education. The day ...
(Date:4/24/2014)... affects more than one out of three survivors ... released in The Lancet Respiratory Medicine , ... physically rather than mentally. , It is one ... health and functional outcomes of critical care survivors, ... professor of Medicine, and it highlights a significant ...
(Date:4/24/2014)... Foundation has awarded LSU Health Sciences Center New ... grant in the amount of $295,635. The funding ... social and educational backgrounds, underrepresented in the sciences, ... project will provide students with training for 10 ... will be led by Principal Investigator Dr. Fern ...
(Date:4/23/2014)... April 24, 2014 Pregnant immigrants from Sub-Saharan ... increased monitoring during pregnancy, according to new research ... today in the British Journal of Obstetrics ... and eclampsia rates among immigrants and native-born women ... (Ontario), Denmark, Sweden, Spain (Catalonia and Valencia) and ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Pregnancy complications may be more common in immigrants from certain regions 2
... divorce are over twice as likely to suffer a stroke ... presented in New Orleans at The Gerontological Society of ... This finding is based on a representative community sample of ... The data analysis was conducted by Esme Fuller-Thomson, PhD ...
... SATURDAY, Nov. 20 (HealthDay News) -- Kidney failure patients ... prescribed had significantly better heart function, overall health and ... finding stems from an analysis that compared the impact ... treatments per week, for three to four hours per ...
... challenges the current staging system that determines the extent ... Published early online in CANCER , a peer-reviewed ... that there is no link between localized prostate cancer,s ... after having his prostate removed. One of the ...
... Urinary Protein Predict More Rapid Cognitive Decline in Elderly ... A new study has found that low amounts ... considered clinically significant, strongly predict faster cognitive decline in ... aged >70 years in the Nurses, Health Study who ...
... Reporter , FRIDAY, Nov. 19 (HealthDay News) -- The ... the U.S. market because they,ve been linked to serious ... The U.S. Food and Drug Administration said Xanodyne ... voluntarily taking the drugs off the market. The active ...
... HealthDay Reporter , FRIDAY, Nov. 19 (HealthDay ... wearing helmets in the United States, more serious head ... medical costs, two new companion studies show. In ... sustained in motorcycle crashes involving 12- to 20-year-olds resulted ...
Cached Medicine News:Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 2Health News:Doubling Frequency of Dialysis May Help Kidney Failure Patients 3Health News:Protein in the urine: A warning sign for cognitive decline 2Health News:Protein in the urine: A warning sign for cognitive decline 3Health News:FDA Pulls Darvon and Companion Drug Due to Heart Risks 2Health News:FDA Pulls Darvon and Companion Drug Due to Heart Risks 3Health News:Young Motorcycle Riders Suffering More Brain Injuries 2Health News:Young Motorcycle Riders Suffering More Brain Injuries 3
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... NEW YORK, Feb. 23, 2012 Monthly Prescribing Reference (MPR) ... Drugs & Bugs App , an essential resource ... spectrum of efficacy against microorganisms. Clinicians may use the searchable ... or pharmacological class to begin their query. The ...
... A new imaging efficiency measure developed by ... to reduce CT scans in emergency departments does ... scans inappropriately, according to a new study published ... ("Assessment of Medicare,s Imaging Efficiency Measure for ...
Cached Medicine Technology:Drugs & Bugs: A New App from Monthly Prescribing Reference 2Drugs & Bugs: A New App from Monthly Prescribing Reference 3Government Rule Designed to Limit CT Scans in ERs Is Unreliable, Invalid and Inaccurate, Says ACEP 2
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Calibration Plasmas for Assaysof Unfractionated Heparins (UFH) using the Anti-Xa Method on STA© Analyzers....
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
Fructosamine Calibrator...
Medicine Products: